Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ene.14440 http://scihub22266oqcxt.onion/10.1111/ene.14440 32677329!7405216!32677329     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Neurol 2020 ; 27 (11): 2318-2321 Nephropedia Template TP {{tp|p=32677329|t=2020. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak |pdf=|usr=}}{{32677329}} gab.com Text Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak JO: Eur J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32677329 #FOAvip BACKGROUND AND PURPOSE: Post-viral olfactory dysfunction is well established and has been shown to be a key symptom of COVID-19 with more than 66% of European and US patients reporting some degree of loss of smell. Persistent olfactory dysfunction appears to be commonplace and will drive the demand for general practitioner, otolaryngology or neurology consultation in the next few months - evidence regarding recovery will be essential in counselling our patients. METHODS: This was a prospective survey-based data collection and telemedicine follow-up. RESULTS: In total, 751 patients completed the study, of whom 477 were females and 274 males. The mean age of the patients was 41 +/- 13 years (range 18-60). There were 621 patients (83%) who subjectively reported a total loss of smell and 130 (17%) a partial loss. After a mean follow-up of 47 +/- 7 days (range 30-71) from the first consultation, 277 (37%) patients still reported a persistent subjective loss of smell, 107 (14%) reported partial recovery and 367 (49%) reported complete recovery. The mean duration of the olfactory dysfunction was 10 +/- 6 days (range 3-31) in those patients who completely recovered and 12 +/- 8 days (range 7-35) in those patients who partially recovered. CONCLUSIONS: According to our results, at this relatively early point in the pandemic, subjective patterns of recovery of olfactory dysfunction in COVID-19 patients are valuable for our patients, for hypothesis generation and for treatment development. Twit Text FOAVip Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak ????Eur J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=32677329 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32677329 #FOAvip English Wikipedia <ref>{{Cite pmid|32677329}}</ref> Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak #MMPMID32677329 Chiesa-Estomba CM; Lechien JR; Radulesco T; Michel J; Sowerby LJ; Hopkins C; Saussez S Eur J Neurol 2020[Nov]; 27 (11): 2318-2321 PMID32677329show ga BACKGROUND AND PURPOSE: Post-viral olfactory dysfunction is well established and has been shown to be a key symptom of COVID-19 with more than 66% of European and US patients reporting some degree of loss of smell. Persistent olfactory dysfunction appears to be commonplace and will drive the demand for general practitioner, otolaryngology or neurology consultation in the next few months - evidence regarding recovery will be essential in counselling our patients. METHODS: This was a prospective survey-based data collection and telemedicine follow-up. RESULTS: In total, 751 patients completed the study, of whom 477 were females and 274 males. The mean age of the patients was 41 +/- 13 years (range 18-60). There were 621 patients (83%) who subjectively reported a total loss of smell and 130 (17%) a partial loss. After a mean follow-up of 47 +/- 7 days (range 30-71) from the first consultation, 277 (37%) patients still reported a persistent subjective loss of smell, 107 (14%) reported partial recovery and 367 (49%) reported complete recovery. The mean duration of the olfactory dysfunction was 10 +/- 6 days (range 3-31) in those patients who completely recovered and 12 +/- 8 days (range 7-35) in those patients who partially recovered. CONCLUSIONS: According to our results, at this relatively early point in the pandemic, subjective patterns of recovery of olfactory dysfunction in COVID-19 patients are valuable for our patients, for hypothesis generation and for treatment development. |Administration, Intranasal[MESH] |Adolescent[MESH] |Adrenal Cortex Hormones/administration & dosage/therapeutic use[MESH] |Adult[MESH] |COVID-19/*complications/*therapy[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Olfaction Disorders/*etiology/*therapy[MESH] |Pandemics[MESH] |Prospective Studies[MESH] |Recovery of Function[MESH] |Surveys and Questionnaires[MESH] |Telemedicine[MESH] |Treatment Outcome[MESH]Patterns of smell recovery in 751 patients affected by the COVID-19 ou(epmc).pdf DeepDyve Pubget Overpricing